Darifenacin inactive ingredients by manufacturer
Wondering whether your Darifenacin has lactose, gluten, soy, a dye or gelatin in it? The medicine is the same, but the fillers, coatings and colors differ from one company to the next. This page shows what each Darifenacin product's FDA label lists, so you can find a version that leaves out what you avoid and ask your pharmacist for it by its NDC.
We have read the FDA labels of 11 of the 16 current Darifenacin products on the market today, from 8 companies listing it with the FDA, and lined them up side by side. 5 are still being read and will appear on a later visit.
Ask about your bottle
Is there something in your Darifenacin? Ask in plain words.
Name the company, strength or the NDC on your bottle and the ingredient you avoid. The answer comes only from the FDA labels on this page.
Answers are drawn from the FDA label data on this page and checked against it. They are not medical advice: confirm with your pharmacist before relying on them.
The short answer
Which Darifenacin products list lactose, a gluten source, soy, dyes or gelatin?
-
LactoseDiffers by manufacturer
3 of 11 checked products list lactose; 8 do not. See the products
-
Wheat or gluten sourceNo checked product
No checked Darifenacin product lists a wheat or gluten source.
-
SoyNo checked product
No checked Darifenacin product lists soy.
-
Synthetic dyesNo checked product
No checked Darifenacin product lists synthetic dyes.
-
GelatinNo checked product
No checked Darifenacin product lists gelatin.
Also listed by some products: Titanium dioxide 11 of 11 PEG or polysorbate 11 of 11
Find a version without it
Every current Darifenacin product and what its label lists
| Product | Lists | Inactive ingredients on the label |
|---|---|---|
| Alembic Pharmaceuticals Inc. 2 products | ||
| 7.5 mg extended-release tabletNDC 62332-0223-08 | Still being read | Not read yet |
| 15 mg extended-release tabletNDC 62332-0224-08 | Titanium dioxide Polyethylene glycol or polysorbate |
Show 9 ingredientsCALCIUM PHOSPHATE, DIBASIC, ANHYDROUS, FERRIC OXIDE RED, FERRIC OXIDE YELLOW, HYPROMELLOSES, MAGNESIUM STEARATE, POLYETHYLENE GLYCOL 1500, POVIDONE K30, TALC, TITANIUM DIOXIDE |
| Alembic Pharmaceuticals Limited 2 products | ||
| 7.5 mg extended-release tabletNDC 46708-0223-08 | Titanium dioxide Polyethylene glycol or polysorbate |
Show 7 ingredientsANHYDROUS DIBASIC CALCIUM PHOSPHATE, HYPROMELLOSE, UNSPECIFIED, MAGNESIUM STEARATE, POLYETHYLENE GLYCOL 1500, POVIDONE K30, TALC, TITANIUM DIOXIDE |
| 15 mg extended-release tabletNDC 46708-0224-08 | Still being read | Not read yet |
| Aurobindo Pharma Limited 2 products | ||
| 7.5 mg extended-release tabletNDC 65862-0861-05 | Lactose Titanium dioxide Polyethylene glycol or polysorbate |
Show 12 ingredientsDIBASIC CALCIUM PHOSPHATE DIHYDRATE, ETHYLCELLULOSE (10 MPA.S), HYDROXYETHYL CELLULOSE (4000 MPA.S AT 1%), HYDROXYPROPYL CELLULOSE (1600000 WAMW), HYPROMELLOSE 2910 (5 MPA.S), LACTOSE MONOHYDRATE, MAGNESIUM STEARATE, POLYETHYLENE GLYCOL 6000, POVIDONE K30, SILICON DIOXIDE, TALC, TITANIUM DIOXIDE |
| 15 mg extended-release tabletNDC 65862-0862-05 | Lactose Titanium dioxide Polyethylene glycol or polysorbate |
Show 14 ingredientsDIBASIC CALCIUM PHOSPHATE DIHYDRATE, ETHYLCELLULOSE (10 MPA.S), FERRIC OXIDE RED, FERRIC OXIDE YELLOW, HYDROXYETHYL CELLULOSE (4000 MPA.S AT 1%), HYDROXYPROPYL CELLULOSE (1600000 WAMW), HYPROMELLOSE 2910 (5 MPA.S), LACTOSE MONOHYDRATE, MAGNESIUM STEARATE, POLYETHYLENE GLYCOL 6000, POVIDONE K30, SILICON DIOXIDE, TALC, TITANIUM DIOXIDE |
| Bryant Ranch Prepack 2 products | ||
| 7.5 mg extended-release tabletNDC 72162-2570-03 | Still being read | Not read yet |
| 15 mg extended-release tabletNDC 72162-2571-03 | Titanium dioxide Polyethylene glycol or polysorbate |
Show 10 ingredientsFERRIC OXIDE RED, FERRIC OXIDE YELLOW, HYPROMELLOSE 2208 (4000 MPA.S), HYPROMELLOSE 2910 (15 MPA.S), MAGNESIUM STEARATE, MICROCRYSTALLINE CELLULOSE, POLYETHYLENE GLYCOL 400, SILICON DIOXIDE, TALC, TITANIUM DIOXIDE |
| Cipla USA Inc. 2 products | ||
| 7.5 mg extended-release tabletNDC 69097-0431-02 | Titanium dioxide Polyethylene glycol or polysorbate |
Show 6 ingredientsANHYDROUS DIBASIC CALCIUM PHOSPHATE, HYPROMELLOSE 2910 (3 MPA.S), MAGNESIUM STEARATE, POLYETHYLENE GLYCOL 4000, TALC, TITANIUM DIOXIDE |
| 15 mg extended-release tabletNDC 69097-0432-02 | Titanium dioxide Polyethylene glycol or polysorbate |
Show 8 ingredientsANHYDROUS DIBASIC CALCIUM PHOSPHATE, FERRIC OXIDE RED, FERRIC OXIDE YELLOW, HYPROMELLOSE 2910 (3 MPA.S), MAGNESIUM STEARATE, POLYETHYLENE GLYCOL 4000, TALC, TITANIUM DIOXIDE |
| Macleods Pharmaceuticals Limited 2 products | ||
| 7.5 mg extended-release tabletNDC 33342-0276-07 | Titanium dioxide Polyethylene glycol or polysorbate |
Show 7 ingredientsCALCIUM PHOSPHATE, DIBASIC, ANHYDROUS, HYPROMELLOSE, UNSPECIFIED, MAGNESIUM STEARATE, POLYETHYLENE GLYCOL, UNSPECIFIED, SILICON DIOXIDE, TALC, TITANIUM DIOXIDE |
| 15 mg extended-release tabletNDC 33342-0277-07 | Titanium dioxide Polyethylene glycol or polysorbate |
Show 9 ingredientsCALCIUM PHOSPHATE, DIBASIC, ANHYDROUS, FERRIC OXIDE RED, FERRIC OXIDE YELLOW, HYPROMELLOSE, UNSPECIFIED, MAGNESIUM STEARATE, POLYETHYLENE GLYCOL, UNSPECIFIED, SILICON DIOXIDE, TALC, TITANIUM DIOXIDE |
| Rising Pharma Holdings, Inc. 2 products | ||
| 7.5 mg extended-release tabletNDC 16571-0767-03 | Lactose Titanium dioxide Polyethylene glycol or polysorbate |
Show 12 ingredientsDIBASIC CALCIUM PHOSPHATE DIHYDRATE, ETHYLCELLULOSE (10 MPA.S), HYDROXYETHYL CELLULOSE (4000 MPA.S AT 1%), HYDROXYPROPYL CELLULOSE (1600000 WAMW), HYPROMELLOSE 2910 (5 MPA.S), LACTOSE MONOHYDRATE, MAGNESIUM STEARATE, POLYETHYLENE GLYCOL 6000, POVIDONE K30, SILICON DIOXIDE, TALC, TITANIUM DIOXIDE |
| 15 mg extended-release tabletNDC 16571-0768-03 | Still being read | Not read yet |
| Torrent Pharmaceuticals Limited 2 products | ||
| 7.5 mg extended-release tabletNDC 13668-0202-05 | Titanium dioxide Polyethylene glycol or polysorbate |
Show 8 ingredientsCELLULOSE, MICROCRYSTALLINE, HYPROMELLOSE 2208 (4000 MPA.S), HYPROMELLOSE 2910 (15 MPA.S), MAGNESIUM STEARATE, POLYETHYLENE GLYCOL 400, SILICON DIOXIDE, TALC, TITANIUM DIOXIDE |
| 15 mg extended-release tabletNDC 13668-0203-05 | Still being read | Not read yet |
A product with none of these listed is not certified to be without them: the label says what the manufacturer declared, and the source of a starch or a flavor is often not stated. The companies are the FDA's labelers, which include repackagers and distributors selling another company's product under their own label. The NDC opens the product's own page, with the full label and its inactive-ingredient notes.
Darifenacin without lactose
Lactose: milk sugar; a concern with lactose intolerance or a milk allergy. 3 of 11 checked products list lactose; 8 do not.
Does not list lactose
- Alembic Pharmaceuticals Inc.: 15 mg extended-release tablet
- Alembic Pharmaceuticals Limited: 7.5 mg extended-release tablet
- Bryant Ranch Prepack: 15 mg extended-release tablet
- Cipla: 7.5 mg extended-release tablet, 15 mg extended-release tablet
- Macleods: 7.5 mg extended-release tablet, 15 mg extended-release tablet
- Torrent: 7.5 mg extended-release tablet
Lists lactose
Darifenacin and titanium dioxide
Titanium dioxide: A white colorant some people choose to avoid. Every checked Darifenacin product (11) lists titanium dioxide.
Lists titanium dioxide
- Alembic Pharmaceuticals Inc.: 15 mg extended-release tablet
- Alembic Pharmaceuticals Limited: 7.5 mg extended-release tablet
- Aurobindo: 7.5 mg extended-release tablet, 15 mg extended-release tablet
- Bryant Ranch Prepack: 15 mg extended-release tablet
- Cipla: 7.5 mg extended-release tablet, 15 mg extended-release tablet
- Macleods: 7.5 mg extended-release tablet, 15 mg extended-release tablet
- Rising: 7.5 mg extended-release tablet
- Torrent: 7.5 mg extended-release tablet
Darifenacin and polyethylene glycol or polysorbate
Polyethylene glycol or polysorbate: PEG, macrogol or polysorbate; a rare cause of allergic reactions. Every checked Darifenacin product (11) lists polyethylene glycol or polysorbate.
Lists polyethylene glycol or polysorbate
- Alembic Pharmaceuticals Inc.: 15 mg extended-release tablet
- Alembic Pharmaceuticals Limited: 7.5 mg extended-release tablet
- Aurobindo: 7.5 mg extended-release tablet, 15 mg extended-release tablet
- Bryant Ranch Prepack: 15 mg extended-release tablet
- Cipla: 7.5 mg extended-release tablet, 15 mg extended-release tablet
- Macleods: 7.5 mg extended-release tablet, 15 mg extended-release tablet
- Rising: 7.5 mg extended-release tablet
- Torrent: 7.5 mg extended-release tablet
At the pharmacy counter
How to use this at the pharmacy counter
- Pick the company whose list suits you and copy the NDC from the table. Many pharmacies order from wholesalers that carry several companies' versions and can request a particular one if you ask before the prescription is filled; some buy from one contracted source only, and a few insurance plans cover only certain NDCs, so ask the pharmacist to check.
- Treat "does not list" as exactly that. The label is what the manufacturer declared; a flavor or a starch may have an unstated source, and lines change. For celiac disease or a serious allergy, ask the manufacturer's medical information line for a written statement about the lot you have.
- Check the bottle each refill. A different company usually means a different shape, color and inactive-ingredient list; the pharmacist can tell you who made it, and the two-NDC comparison shows the difference line by line.
- If you need one company's version kept constant, ask your prescriber to write that company or the NDC on the prescription and tell the pharmacy you need it held. Rules vary by state and plan, so confirm with the pharmacist.
Common questions about Darifenacin inactive ingredients
Is Darifenacin gluten-free?
Does Darifenacin contain lactose?
Does Darifenacin contain soy?
Is there a dye-free Darifenacin?
Does Darifenacin contain gelatin?
Why do the inactive ingredients differ between manufacturers?
Can my pharmacy give me a specific manufacturer's version?
How current is this list?
Sources: the products are the finished Darifenacin products in the FDA's current NDC directory (openFDA), as of October 6, 2026; each inactive-ingredient list is the manufacturer's FDA Structured Product Label via DailyMed, as our label sync last read it. The concern groups are HelloPharmacist's classification of the names the label declares. Educational information only, not medical advice; confirm with your pharmacist before relying on a list. ← Back to the Darifenacin guide